GH Research (GHRS) Long-Term Investments (2021 - 2025)
GH Research (GHRS) recorded quarterly Long-Term Investments of $34.5 million in Q4 2025, down 11.31% quarter-over-quarter from $38.9 million in Q3 2025, and up 3.47% on a YoY basis from $33.3 million in Q4 2024.
GH Research (GHRS) Long-Term Investments (2021 - 2025) Analysis & Trends
GH Research's Long-Term Investments history runs 5 years deep, the most recent figure standing at $34.5 million for Q4 2025.
- In Q4 2025, Long-Term Investments rose 3.47% year-over-year to $34.5 million; the TTM figure through Dec 2025 stood at $34.5 million (up 3.47% YoY), while the FY2025 annual figure was $34.5 million, up 3.47% from the prior year.
- Long-Term Investments was $34.5 million for Q4 2025 at GH Research, down from $38.9 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $122.1 million in Q4 2021 to a low of $33.3 million in Q4 2024.
- Historically, Long-Term Investments has averaged $58.8 million across 5 years, with a median of $54.7 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Long-Term Investments sank 45.54% in 2024, then climbed 3.47% in 2025.
- A 5-year view of Long-Term Investments shows it stood at $122.1 million in 2021, then declined by 29.78% to $85.7 million in 2022, then dropped by 28.68% to $61.1 million in 2023, then slumped by 45.54% to $33.3 million in 2024, then advanced by 3.47% to $34.5 million in 2025.
- The last three Long-Term Investments figures came in at $34.5 million (Q4 2025), $38.9 million (Q3 2025), and $37.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 34.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.46 Mn |
| Sep 30, 2025 | 38.85 Mn |
| Jun 30, 2025 | 37.66 Mn |
| Mar 31, 2025 | 33.84 Mn |
| Dec 31, 2024 | 33.30 Mn |
| Sep 30, 2024 | 43.81 Mn |
| Jun 30, 2024 | 53.17 Mn |
| Mar 31, 2024 | 56.13 Mn |
| Dec 31, 2023 | 61.14 Mn |
| Sep 30, 2023 | 67.45 Mn |
| Jun 30, 2023 | 72.70 Mn |
| Mar 31, 2023 | 83.32 Mn |
| Dec 31, 2022 | 85.72 Mn |
| Dec 31, 2021 | 122.08 Mn |